Cargando…

A New Rise of Non-Human Primate Models of Synucleinopathies

Synucleinopathies are neurodegenerative diseases characterized by the presence of α-synuclein-positive intracytoplasmic inclusions in the central nervous system. Multiple experimental models have been extensively used to understand better the mechanisms involved in the pathogenesis of synucleinopath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teil, Margaux, Arotcarena, Marie-Laure, Dehay, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999604/ https://www.ncbi.nlm.nih.gov/pubmed/33803341 http://dx.doi.org/10.3390/biomedicines9030272

Ejemplares similares

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019)

Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
por: Teil, Margaux, et al.
Publicado: (2020)

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain
por: Teil, Margaux, et al.
Publicado: (2023)

Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019)

Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling
por: Soria, Federico N., et al.
Publicado: (2020)

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
por: Chocarro, Julia, et al.
Publicado: (2023)

Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021)

COVID-19 Research: Lessons from Non-Human Primate Models
por: Albrecht, Laure, et al.
Publicado: (2021)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate
por: Canron, Marie-Hélène, et al.
Publicado: (2012)

Neuropathology and molecular diagnosis of Synucleinopathies
por: Koga, Shunsuke, et al.
Publicado: (2021)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Monitoring α-synuclein aggregation
por: Estaun-Panzano, Juan, et al.
Publicado: (2023)

Non-human primates as a model for human development
por: Nakamura, Tomonori, et al.
Publicado: (2021)

Interests of the Non-Human Primate Models for HIV Cure Research
por: Terrade, Gauthier, et al.
Publicado: (2021)

Neurons and Glia Interplay in α-Synucleinopathies
por: Mavroeidi, Panagiota, et al.
Publicado: (2021)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Fellner, Lisa, et al.
Publicado: (2021)

Phytochemicals as Regulators of Genes Involved in Synucleinopathies
por: Surguchov, Andrei, et al.
Publicado: (2021)

Gaucher disease and the synucleinopathies: refining the relationship
por: Campbell, Tessa N, et al.
Publicado: (2012)

Mechanisms of Neuronal Death in Synucleinopathy
por: Takeda, Atsushi, et al.
Publicado: (2006)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal function
por: Arotcarena, Marie‐Laure, et al.
Publicado: (2022)

Non-Human Primate Models of Enteric Viral Infections
por: Sestak, Karol
Publicado: (2018)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies
por: Sampaio-Marques, Belém, et al.
Publicado: (2015)

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy(1)
por: Jellinger, Kurt A.
Publicado: (2018)

Protein Quality Control Pathways at the Crossroad of Synucleinopathies
por: De Mattos, Eduardo P., et al.
Publicado: (2020)

Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2023)

Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2013)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
por: Mazzotta, Gabriella M., et al.
Publicado: (2023)

Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight
por: Upcott, Matthew, et al.
Publicado: (2021)

Developing Non-Human Primate Models of Inherited Retinal Diseases
por: Seah, Ivan, et al.
Publicado: (2022)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
por: Deyell, Jacob S., et al.
Publicado: (2023)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model
por: Bourdenx, Mathieu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mr9nk3uk5l6glea0n56ba8jm1s